Font Size: a A A
Keyword [Pathological cardiac hypertrophy]
Result: 21 - 35 | Page: 2 of 2
21. Effects And Mechanisms Of S-nitrosylated ANT1 On Pathological Cardiac Hypertrophy
22. Research On The Regulation Mechanism Of Ca_V1.2 C Hannel By CaM And CaMK? In Pathological Myocardial Hypertrophy
23. FAD Ameliorates Pathological Cardiac Hypertrophy And Fibrosis Through Activating SCAD
24. Pop1 Inhibits Pathological Cardiac Hypertrophy Through Geft
25. The Function Of Six-transmembrane Epithelial Antigen Of Prostate 3 In Pathological Cardiac Hypertrophy
26. Alternate routes of calcium entry mediating pathological cardiac hypertrophy
27. Microdomain based calcium influx pathways that regulate pathological cardiac hypertrophy and contractility
28. The Study On The Role And Mechanism Of PTEN And Upstream Proteins In Pathological Cardiac Hypertrophy And Non-Alcoholic Fatty Liver Disease
29. The Function And Mechanisms Of DUSP26 In Pathological Cardiac Hypertrophy
30. The Role And Mechanism Of TMBIM1 On Pathological Cardiac Hypertrophy
31. The Mechanism Of Aerobic Exercise Regulating AMPK-related Signaling Pathway To Alleviate TAC-induced Pathological Cardiac Hypertrophy
32. Alterations And Mechanism Of Delayed Rectifier Potassium Channel In Pathological Cardiac Hypertrophy
33. Study On The Mechanism Of Soluble Guanylate Cyclase Agonist Vericiguat Targeting AMPK/mTOR And Autophagy Pathway To Inhibit Pathological Cardiac Hypertrophy
34. Vaspin Alleviates Pathological Cardiac Hypertrophy By Regulating Autophagy-dependent Myocardial Senescence
35. N-n-butyl Haloperidol Iodide Protects Against Pressure Overload-induced Pathological Cardiac Hypertrophy By Regulating ROS/JNK/Brf1 Pathway In Mice
  <<First  <Prev  Next>  Last>>  Jump to